Onconetix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.76	0.06	-	-	-	-
Cost of Revenue	1.7	1.19	-	-	-	-
Gross Profit	-0.94	-1.13	-	-	-	-
Selling, General & Admin	14.77	12.8	9.05	2.09	1.1	0.82
Research & Development	0.92	1.95	4.13	1.33	0.52	0.06
Operating Expenses	15.69	14.75	13.18	3.42	1.62	0.88
Operating Income	-16.63	-15.88	-13.18	-3.42	-1.62	-0.88
Interest Expense	-1.08	-0.67	-	-	-	-
Interest & Investment Income	-	-	-	-	0.02	0.06
Other Non Operating Income (Expenses)	-0.07	-0.09	0.06	-	-	-
EBT Excluding Unusual Items	-17.78	-16.64	-13.12	-3.42	-1.6	-0.82
Merger & Restructuring Charges	-1.7	-1.7	-	-	-	-
Impairment of Goodwill	-5.19	-	-	-	-	-
Asset Writedown	-17.25	-14.95	-	-	-	-
Other Unusual Items	-3.9	-4.12	-0.3	-	-	-
Pretax Income	-45.82	-37.42	-13.42	-3.42	-1.6	-0.82
Income Tax Expense	-0.13	-0.01	-	-	-	-
Net Income	-45.68	-37.41	-13.42	-3.42	-1.6	-0.82
Preferred Dividends & Other Adjustments	-	-	0.1	0.63	0.56	0.28
Net Income to Common	-45.68	-37.41	-13.52	-4.04	-2.16	-1.1
Shares Outstanding (Basic)	19	17	12	3	3	3
Shares Outstanding (Diluted)	19	17	12	3	3	3
Shares Change (YoY)	27.32%	39.44%	283.48%	-	-	-
EPS (Basic)	-2.45	-2.19	-1.10	-1.26	-0.67	-0.34
EPS (Diluted)	-2.45	-2.19	-1.10	-1.26	-0.67	-0.34
Free Cash Flow	-23.99	-23.16	-8.68	-2.05	-1.74	-0.83
Free Cash Flow Per Share	-1.28	-1.35	-0.71	-0.64	-0.54	-0.26
Gross Margin	-123.62%	-	-	-	-	-
Operating Margin	-2191.12%	-27161.94%	-	-	-	-
Free Cash Flow Margin	-3160.80%	-39620.44%	-	-	-	-
EBITDA	-16.38	-15.84	-13.17	-3.41	-1.62	-0.88
D&A For EBITDA	0.25	0.04	0.01	0	0	0
EBIT	-16.63	-15.88	-13.18	-3.42	-1.62	-0.88

Source: S&P Capital IQ. Standard template.